| Advances in targeting the folate receptor in the treatment/imaging of cancers M Fernández, F Javaid, V Chudasama Chemical science 9 (4), 790-810, 2018 | 524 | 2018 |
| Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones C Bahou, DA Richards, A Maruani, EA Love, F Javaid, S Caddick, ... Organic & biomolecular chemistry 16 (8), 1359-1366, 2018 | 84 | 2018 |
| Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target F Javaid, C Pilotti, C Camilli, D Kallenberg, C Bahou, J Blackburn, ... RSC chemical biology 2 (4), 1206-1220, 2021 | 24 | 2021 |
| A Plug-and-Play Platform for the Formation of Trifunctional Cysteine Bioconjugates that also Offers Control over Thiol Cleavability C Bahou, PA Szijj, RJ Spears, A Wall, F Javaid, A Sattikar, EA Love, ... Bioconjugate Chemistry 32 (4), 672-679, 2021 | 20 | 2021 |
| Use of pyridazinediones as extracellular cleavable Linkers through Reversible Cysteine Conjugation C Bahou, RJ Spears, AE Aliev, A Maruani, M Fernandez, F Javaid, ... Chemical Communications 55 (98), 14829-14832, 2019 | 17 | 2019 |
| A humanized antibody against LRG1 that inhibits angiogenesis and reduces retinal vascular leakage D Kallenberg, V Tripathi, F Javaid, C Pilotti, J George, S Davis, ... BioRxiv, 2020.07. 25.218149, 2020 | 16 | 2020 |
| Synthesis of Tryptophan–Folate Conjugates K Maruyama, KJ Malawska, N Konoue, K Oisaki, M Kanai Synlett 31 (08), 784-787, 2020 | 9 | 2020 |
| Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem Sci 9: 790–810 M Fernández, F Javaid, V Chudasama | 7 | 2018 |
| Structural basis of human LRG1 recognition by Magacizumab, a humanized monoclonal antibody with therapeutic potential J Gutiérrez-Fernández, F Javaid, G De Rossi, V Chudasama, ... Biological Crystallography 78 (6), 725-734, 2022 | 5 | 2022 |
| Correction: Use of pyridazinediones as extracellular cleavable linkers through reversible cysteine conjugation C Bahou, RJ Spears, AE Aliev, A Maruani, M Fernandez, F Javaid, ... Chemical Communications 58 (91), 12740-12740, 2022 | 1 | 2022 |
| Appraisal of Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a target for a potential antibody–drug conjugate (ADC) F Javaid UCL (University College London), 2021 | | 2021 |
